Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

FLJ25371 Inhibitors

FLJ25371 inhibitors represent a class of chemical compounds designed to target and modulate the activity of the protein encoded by the FLJ25371 gene. This gene, also known by alternative designations, encodes a protein with roles in cellular processes such as signal transduction, protein-protein interactions, and regulation of specific molecular pathways. FLJ25371 inhibitors are typically small molecules that bind to this protein or interfere with its function at a biochemical level, disrupting its normal role within the cell. These inhibitors can be tailored to achieve a high degree of specificity, minimizing off-target interactions and maximizing the effective disruption of FLJ25371-associated pathways.

The design and optimization of FLJ25371 inhibitors require a deep understanding of the structural and functional characteristics of the FLJ25371 protein. Researchers often study the three-dimensional structure of the protein, identifying potential binding pockets or sites where inhibition can occur. High-throughput screening and structure-based drug design approaches may be employed to identify lead compounds. These inhibitors can be useful tools for probing the biological functions of FLJ25371 in experimental models, offering insight into the molecular pathways it influences. By utilizing FLJ25371 inhibitors, researchers can better understand the biological significance of this protein, its interactions with other molecules, and its role in complex cellular processes.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

Triciribine is a specific inhibitor of AKT phosphorylation and activation. By inhibiting AKT, it may reduce the signaling pathways necessary for the functional activity of FLJ25371.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Sorafenib is a kinase inhibitor that targets several receptor tyrosine kinases and RAF kinases. Its broad range of targets includes pathways that may be required for FLJ25371 activity, thus potentially leading to its functional inhibition.